Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort
Tóm tắt
The treatment of children with juvenile idiopathic arthritis (JIA) to prevent disability is a major challenge in paediatric rheumatology. The presence of synovitis, which is difficult to detect in children, is associated with structural damage. Musculoskeletal ultrasonography (MSUS) can be used in patients with JIA to reveal subclinical synovitis. The primary aim was to determine whether the use of MSUS was associated with therapeutic modification in patients with JIA. The secondary aim was to identify other factors associated with therapeutic decisions. We conducted an observational study based on the JIRECHO multi-centre cohort, which was developed to provide a systematic MSUS follow-up for patients with JIA. Follow-up occurred every 6 months and included clinical and MSUS examinations. We included children who underwent MSUS of the elbows, wrists, second metacarpophalangeal joints, knees and ankles, which was performed by expert sonographers. Clinical and biological data, disease activity scores and information on therapeutics were collected. A total of 185 visits concerning 112 patients were recorded. Three groups were defined according to the therapeutic decision: escalation (22%, n = 40), de-escalation (14%, n = 26) or stable (64%, n = 119). In the “therapeutic escalation” group: the presence of ultrasonographic synovitis in B-mode and the presence of grade 2 or 3 synovitis in B-mode were not significantly more frequent than in the “stable therapeutic or de-escalation” group (80% versus 65%, p = 0.06; 33% versus 19%, p = 0.06), and the patient’s and physician’s visual analogue scale (VAS) scores, the clinical JADAS and the C-reactive protein level were significantly higher, but only physician’s VAS score remained in the model of logistic regression. In the “therapeutic de-escalation” group: there was no difference in the presence of US synovitis compared with the “stable therapeutic or escalation” group (62% versus 69%, p = 0.48). Even though US synovitis tended to be more frequent in patients with therapeutic escalation, the study did not show that the presence of synovitis in MSUS was statistically associated with therapeutic modifications in patients with JIA. Treatment remained stable despite the presence of US synovitis.
Tài liệu tham khảo
Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet Lond Engl. 2011;377:2138–49. https://doi.org/10.1016/S0140-6736(11)60244-4.
Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Pediatr Clin North Am. 2005;52(413–42):vi. https://doi.org/10.1016/j.pcl.2005.01.007.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
Bader-Meunier B. Protocole National de Diagnostic et de Soins: Arthrites Juvéniles Idiopathiques. 2017.
Stringer E, Bohnsack J, Bowyer SL, Griffin TA, Huber AM, Lang B, et al. Treatment approaches to juvenile dermatomyositis (JDM) across North America: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. J Rheumatol. 2010;37:1953–61. https://doi.org/10.3899/jrheum.090953.
Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658–66. https://doi.org/10.1002/art.24516.
Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Centre for Reviews and Dissemination (UK). 2008.
Marteau P, Adamsbaum C, Rossi-Semerano L, De Bandt M, Lemelle I, Deslandre C, et al. Conventional radiography in juvenile idiopathic arthritis: joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology. Eur Radiol. 2018;28:3963–76. https://doi.org/10.1007/s00330-018-5304-7.
Quartier P. Critères et indices de réponse au traitement et de rémission des arthrites juvéniles idiopathiques. Rev Rhum Monogr. 2010;77:96–8. https://doi.org/10.1016/j.monrhu.2010.04.014.
Prieur AM, Chèdeville G. Prognostic factors in juvenile idiopathic arthritis. Curr Rheumatol Rep. 2001;3:371–8. https://doi.org/10.1007/s11926-996-0006-6.
Breton S, Jousse-Joulin S, Cangemi C, de Parscau L, Colin D, Bressolette L, et al. Comparison of clinical and ultrasonographic evaluations for peripheral synovitis in juvenile idiopathic arthritis. Semin Arthritis Rheum. 2011;41:272–8. https://doi.org/10.1016/j.semarthrit.2010.12.005.
Jousse-Joulin S, Breton S, Cangemi C, Fenoll B, Bressolette L, de Parscau L, et al. Ultrasonography for detecting enthesitis in juvenile idiopathic arthritis. Arthritis Care Res. 2011;63:849–55. https://doi.org/10.1002/acr.20444.
Breton S, Jousse-Joulin S, Finel E, Marhadour T, Colin D, de Parscau L, et al. Imaging approaches for evaluating peripheral joint abnormalities in juvenile idiopathic arthritis. Semin Arthritis Rheum. 2012;41:698–711. https://doi.org/10.1016/j.semarthrit.2011.08.004.
Darwish AF, Ismael FM, Ell-Laban A, Hamed A, Kader MA, Osman A. Implementation of musculoskeletal ultrasonography in detection of early juvenile idiopathic arthritis. Eur J Radiol Open. 2016;3:264–71. https://doi.org/10.1016/j.ejro.2016.11.001.
Silva V, Mitraud S, Furtado R, Natour J, Len C, Terreri M. Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study. Pediatr Rheumatol. 2017;2017:15. https://doi.org/10.1186/s12969-017-0208-7.
Haavardsholm EA, Aga A-B, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ. 2016;354: i4205. https://doi.org/10.1136/bmj.i4205.
Jousse-Joulin S. Pragmatic study comparing the clinical evlauation methods (C) and/or ultrasound method (B or D) in rheumatoid arthritis (RA) to adapt treatment. clinicaltrials.gov. 2020.
Fondation RES. JIRCohort. jircohorte.org n.d. 2022.
Vojinovic J, Magni-Manzoni S, Collado P, Windschall D, Ravagnani V, Hernandez-Diaz C, et al. Ultrasonography definitions for synovitis grading in children: the OMERACT pediatric ultrasound task force. Ann Rheum Dis. 2017. https://doi.org/10.1136/annrheumdis-2017-eular.6199.
Roth J, Ravagnani V, Backhaus M, Balint P, Bruns A, Bruyn GA, et al. Preliminary definitions for the sonographic features of synovitis in children. Arthritis Care Res. 2017;69:1217–23. https://doi.org/10.1002/acr.23130.
Rossi-Semerano L, Breton S, Semerano L, Boubaya M, Ohanyan H, Bossert M, et al. Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exercise. Rheumatol Oxf Engl. 2020. https://doi.org/10.1093/rheumatology/keaa804.
Consolaro A, Giancane G, Schiappapietra B, Davì S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol. 2016;14:23. https://doi.org/10.1186/s12969-016-0085-5.
Faekah G, Daniel W. The new role of musculoskeletal ultrasound in the treat-to-target management of juvenile idiopathic arthritis. Rheumatol Oxf Engl. 2021;2021:60. https://doi.org/10.1093/rheumatology/keab004.
Rebollo-Polo M, Koujok K, Weisser C, Jurencak R, Bruns A, Roth J. Ultrasound findings on patients with juvenile idiopathic arthritis in clinical remission. Arthritis Care Res. 2011;63:1013–9. https://doi.org/10.1002/acr.20478.
Nieto-González JC, Rodríguez A, Gámir-Gámir ML, Boteanu A, López-Robledillo JC, Garulo DC, et al. Can ultrasound-detected subclinical synovitis be an indicator of flare recurrence in juvenile idiopathic arthritis remission patients on tapered TNFi? Clin Exp Rheumatol. 2019;37:705–12.
Mouterde G, Gandjbakhch F, Le Goff B, Gaudin P, D’Agostino M-A. Recommendations for the pragmatic use of ultrasound in rheumatoid arthritis by the GEISPER French group. Joint Bone Spine. 2021;88: 105187. https://doi.org/10.1016/j.jbspin.2021.105187.
Garrigues F, Jousse-Joulin S, Bouttier R, Nonent M, Bressollette L, Saraux A. Concordance between clinical and ultrasound findings in rheumatoid arthritis. Joint Bone Spine. 2013;80:597–603. https://doi.org/10.1016/j.jbspin.2013.03.011.
Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis. 2005;64:375–81. https://doi.org/10.1136/ard.2004.023929.
Gossec L, Fautrel B, Pham T, Combe B, Flipo R-M, Goupille P, et al. Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine. 2005;72:229–34. https://doi.org/10.1016/j.jbspin.2004.10.011.
Scirè CA, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatol Oxf Engl. 2009;48:1092–7. https://doi.org/10.1093/rheumatology/kep171.
Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–67. https://doi.org/10.1002/art.23945.
Collado P, Naredo E, Calvo C, Gamir ML, Calvo I, García ML, et al. Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis. Rheumatol Oxf Engl. 2013;52:1477–84. https://doi.org/10.1093/rheumatology/ket148.